Arama

EISSN 2148-5607

TJG IS INDEXED IN WEB OF SCIENCE AND PUBMED IMPACT FACTOR: 1.2

Turkish Journal of Gastroenterology

PDF

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 9 results

Ranking

Release Date Sort Sort Article Type

Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome

Oktay YENER, Fikret AKSOY, Mustafa DEMİR, Alp ÖZÇELIK

(Turk J Gastroenterol 2010; 21: 411-415) DOI: 10.4318/tjg.2010.0128

Abstract Full Text ( PDF) Related Articles

Obesity and related parameters of non-alcoholic steatohepatitis

Ender SERİN, Hikmet AKKIZ, Figen DORAN, Yüksel GÜMÜRDÜLÜ, Derya GÜMÜRDÜLÜ

(Turk J Gastroenterol 2002; 13: 71-77)

Abstract Full Text ( PDF) Related Articles

Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis

Mehmet KORUK, Seyithan TAYŞİ, M. Cemil SAVAŞ, Ömer YILMAZ, Fatih AKÇAY, Metin KARAKÖK

(Turk J Gastroenterol 2003; 14: 12-17)

Abstract Full Text ( PDF) Related Articles

Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome

Obesity and related parameters of non-alcoholic steatohepatitis

Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis

Nonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management

The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters

Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis

Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience

Therapeutic Effect of Crocin on the NASH Model by Targeting the Fas Receptor Signaling Pathway

Liver Fatty Acid-binding Protein Is a More Reliable Biomarker for Liver Injury in Nonalcoholic Steatohepatitis than Other Etiologies of Hepatitis